Previous Article | Next Article ![]()
Journal of Clinical Microbiology, September 1998, p. 2542-2547, Vol. 36, No. 9
Department of Arctic Veterinary Medicine,
Received 20 October 1997/Returned for modification 15 April
1998/Accepted 4 June 1998
Orthopoxviruses are being increasingly used as live recombinant
vectors for vaccination against numerous infectious diseases in humans,
domestic animals, and wildlife. For risk assessments and surveillance,
information about the occurrence, distribution and ecology of
orthopoxviruses in western Europe is important but has mainly been
based on serological investigations. We have examined kidneys, lungs,
spleens, and livers of Norwegian small rodents and common shrews
(Sorex araneus) for the presence of orthopoxvirus DNA
sequences by PCR with primers complementary to the viral thymidine
kinase (TK) gene. PCR amplicons were verified as orthopoxvirus specific
by hybridization with a vaccinia virus TK-specific probe. A total of
347 animals (1,388 organs) from eight locations in different parts of
Norway, collected at different times of the year during 1993 to 1995, were examined. Fifty-two animals (15%) from five locations, up to
1,600 km apart, carried orthopoxvirus DNA in one or more of their
organs, most frequently in the lungs. These included 9 of 68 (13%)
bank voles (Clethrionomys glareolus), 4 of 13 (31%)
gray-sided voles (Clethrionomys rufocanus), 3 of 11 (27%)
northern red-backed voles (Clethrionomys rutilus), 16 of 76 (21%) wood mice (Apodemus sylvaticus), and 20 of 157 (13%) common shrews. The previous isolation of cowpox virus from two
clinical cases of infection (human and feline) at two of the locations
investigated suggests that the viruses detected are cowpox and that
some of the virus-carrying small mammalian species should be included
among the cowpox virus natural reservoir hosts in Scandinavia and
western Europe.
Cowpox virus, vaccinia virus, and
some close relatives are classified within the genus
Orthopoxvirus of the Poxviridae family. Infection
and disease due to cowpox virus have been described in humans and
numerous animal species (5) from Europe and western states
of the former USSR. Despite its name, cowpox virus infections seem to
be rare in cattle (2), while an increasing number of cowpox
virus infections in domestic cats and people have been reported during
the last 20 years (6, 7, 21, 38, 43). The natural reservoir
species for such viruses have not been conclusively identified,
although circumstantial evidence and serological data have led to wide
acceptance of the suggestion that some rodent species may serve as
natural reservoirs for such viruses (3, 12, 26). Isolation
of cowpox virus from rodents has, however, been successful only from
Turkmenian big gerbils (Rhombomys opimus) and yellow susliks
(Citellus fulvus) (24) and from a Russian root
vole (Microtus oeconomus) (34).
The species diversity of orthopoxviruses and their host animals in
European wildlife have not been determined. Neither has the
epidemiology nor ecology of cowpox viruses been elucidated in detail.
Recent serological screenings of Norwegian rodents, common shrews
(Sorex araneus), and red foxes (Vulpes vulpes), as well as carnivores from Sweden and Finland, have indicated that
orthopoxviruses are widely distributed in these countries (39,
40). In 1994, the first two recognized Norwegian cases of cowpox
virus infection were diagnosed in a woman (30) and a
domestic cat (41), respectively. These cases emerged within the same part of the country, but without any obvious epidemiological links between them.
Orthopoxviruses are being utilized as live recombinant vaccine vectors
for humans, domestic animals, and wildlife (33). Intraspecies recombination and interspecies recombination for such
viruses have been proven, and this quality is being exploited for
construction of vaccines and expression vectors (28). It is
important to attain more profound knowledge about naturally occurring
relatives that genetically engineered orthopoxviruses might encounter.
All published screenings for orthopoxviruses in Europe have so far been
based on serological methods (3, 12, 19, 25, 31, 34, 39,
40). Such investigations demonstrate the collective number of
animals that have been infected at some time during their lifetime. The
aim of the present study was to estimate the prevalence of
virus-infected individuals within a population at the moment of
sampling, by detecting orthopoxvirus-specific DNA in tissues by PCR. We
report evidence of orthopoxviruses in small mammalian wildlife species
from western Europe, as well as some traits of viral ecology.
Animals.
All animals (Table 1)
were trapped (Ugglan special; Grahn AB, Hillerstorp, Sweden),
anesthetized with ether, and bled. Most of the common shrews, however,
were dead at the time of trap inspection. The animals were examined for
ectoparasites and weighed, and, when possible, the sex was determined
before the corpses were frozen on dry ice for further processing in the
laboratory.
Preparation of tissue for PCR.
From each animal
(n = 347), samples from spleen (10 mg), liver (25 mg),
kidney (25 mg), and lung (25 mg) were excised and stored separately.
All samples were mechanically homogenized before the QIAamp tissue kit
(QIAGEN GmbH, Düsseldorf, Germany) was used for DNA extraction,
bringing the DNA eluate to a final volume of 200 µl in 10 mM Tris-HCl
(pH 9.0). The concentrations of DNA in the eluates ranged from 10 µg/ml for lung samples to 45 µg/ml for liver samples. Five
microliters of this eluate, corresponding to 50 to 225 ng of DNA, was
used as a template in the PCR.
Oligonucleotide primers.
The thymidine kinase (TK)-PCR was
designed to detect all known species belonging to the genus
Orthopoxvirus. The GCG database (GCG software package,
version 8.0; University of Wisconsin Genetics Computer Group, Madison)
was used to compare the base sequences of the TK genes from different
orthopoxviruses. The primers used for amplification of part of the TK
gene were selected from the published sequences of the vaccinia virus
TK gene (GenBank accession no. J02425) (17), the monkeypox
and variola virus TK genes (GenBank accession no. K02025)
(13), and the camelpox virus TK gene (GenBank accession no.
S51129) (8). The primers were checked for
self-complementarity according to the method of Innis et al.
(18). The ortho-TK-1 primer (sense) was
5'-AAAAGTACAGAATTAATTAG-3' (positions 273 to 292; numbering
according to that of Hruby et al. [17]) and the
ortho-TK-2 primer (antisense) was 5'-TTCAGATAATGGAATAAGAT-3' (positions 611 to 592); ortho-TK-1 and ortho-TK-2 were used for the 5' and 3' primers, respectively, and were expected to give a PCR
amplicon of 339 bp (Fig. 1).
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Naturally Occurring Orthopoxviruses: Potential for
Recombination with Vaccine Vectors
![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
TABLE 1.
Species, number, location, and year of trapping of
animals examined for orthopoxvirus infection

View larger version (44K):
[in a new window]
FIG. 1.
Nucleotide sequence of the vaccinia virus TK gene and
its flanking regions (17). The positions of the PCR primers
are shown in boldface and are underlined. The BspDI
(position 465) and EcoRI (position 498) cleavage sites are
underlined. The start codon for translation is shown in boldface and
italics.
Positive controls for the TK-PCR. VV-WR (vaccinia virus strain Western Reserve, VR-119) and CPV-BR (cowpox virus strain Brighton, VR-302), both received from the American Type Culture Collection (ATCC), Rockville, Md., were propagated in Vero cells (ATCC, 81 CCL) and purified as described elsewhere (42). DNA was extracted from the virions by using the QIAamp tissue kit. Pure ectromelia virus DNA (strain Moscow) was a kind gift from M. Buller (St. Louis University Health Sciences Center, St. Louis, Mo.). One picogram and 10 fg of vaccinia virus DNA were routinely used as a template for the positive controls in the screening.
TK-PCR procedure.
Strict precautions were taken to avoid
false-positive PCR (20), and all tissue extractions, PCR
steps, and blottings or hybridizations were done at separate locations.
The TK-PCR was performed with a Gene Amp PCR system 9600 (Perkin Elmer
Cetus Corp., Norwalk, Conn.). The reaction volume was 50 µl, and the mixture contained PCR buffer (10 mM Tris-HCl [pH 8.3], 1.5 mM MgCl2, 50 mM KCl, 0.001% gelatin), 0.5 µM (each) primer,
0.2 mM (each) deoxynucleoside triphosphates (Promega Corp., Madison, Wis.), and 2.5 U of thermostable polymerase (AmpliTaq; Perkin-Elmer Cetus Corp.). The final reaction mixture, except for the polymerase, was prepared de novo, split into equal aliquots, and frozen at
20°C
before use. The reaction tubes were moved from ice to a 95°C heating
block. This temperature was held for 5 min before the cycling program
started. Five cycles of denaturation at 95°C for 30 s and then
annealing at 53°C for 2 min and primer extension at 72°C for
30 s were followed by 35 cycles of 95°C for 30 s, 53°C
for 30 s, and 72°C for 30 s. After the last cycle, the
temperature was held at 72°C for 10 more min to ensure full primer
extension. Optimization strategies were performed according to
guidelines given by Rolfs et al. (36). Optimization was done
with 0.5 µg of mouse genomic DNA as background to mimic the
maximum content of sample DNA in a PCR tube upon analysis.
Agarose gel electrophoresis. The TK-PCR amplicons were analyzed by electrophoresis in horizontal 0.9% (wt/vol) agarose gels (SeaKem LE; FMC BioProducts, Rockland, Maine) in 1× TAE buffer (0.04 M Tris-acetate, 1.0 mM EDTA) and with 0.001% (wt/vol) ethidium bromide incorporated for DNA staining. Fifteen microliters of PCR products was mixed with 3 µl of a 6× loading buffer (0.25% [wt/vol] bromphenol blue, 40% [wt/vol] sucrose) and loaded in each well. Ten microliters of a 10×-diluted solution of 1-kb DNA ladder (Gibco, BRL, Gaithersburg, Md.) was used as a DNA size marker. Gels were run in 1× TAE buffer at 120 V for 1 h. The PCR products were visualized and photographed on a UV transilluminator (model TM-40; Chromato Vue, San Gabriel, Calif.).
Restriction endonuclease digestion of TK-PCR amplicons. Amplicons from positive controls were digested with the restriction enzymes BspDI (New England Biolabs, Inc., Beverly, Mass.) and EcoRI (Promega). Fragments were separated in a horizontal 2.5% (wt/vol) agarose gel (MetaPhor, FMC BioProducts) in 1× TAE buffer with ethidium bromide incorporated for DNA staining. Twenty microliters of fragments and 4 µl of 6× loading buffer were loaded in each well. The gel was run in 0.5× TAE buffer at 80 V for 1.5 h.
Southern blot analysis to confirm specific TK-PCR
amplification.
In order to increase the detection level, we chose
to combine PCR with Southern blotting for all samples. The DNA in the
gels was denatured and blotted on a Hybond-N nylon membrane (Amersham, Buckinghamshire, England) by standard procedures (37).
Blotting and hybridization were executed with 45 ng of probe by
standard protocols (11). The hybridizations were performed
at 65°C, employing a 226-bp labeled probe with a G+C content of 34%
(i.e., under very stringent conditions). The probe was made by
EcoRI restriction endonuclease (Promega) digestion of the
TK-PCR amplicon from VV-WR. The two fragments were separated on a 1.3%
agarose gel (SeaKEM LE). The larger fragment (226 bp) was cut out of
the gel, purified by centrifugation through a glass microfiber filter
(Whatman GF/A; Kent, England) at 15,000 × g for 10 min, and labeled with [
-32P]dCTP (10 µCi/µl)
(Easytides; Dupont Research Products, Boston, Mass.) by using random
primer labeling (Rediprime DNA; Amersham). Following hybridization, the
membranes were washed and exposed to Cronex 4 medical X-ray film
(Dupont, Bad Homburg, Germany) at
70°C for various times for
detection of hybridization signals.
Oligonucleotide primers, conditions, and verification of ATIP-PCR. To be able to exclude ectromelia virus as an origin of detected DNA in the small mammals, we used another pair of primers complementary to the A-type inclusion protein (ATIP) gene of VV-WR and CPV-BR. Because of a heterologous sequence within the ATIP-3 primer binding site (32), this primer is not able to bind to the ectromelia virus ATIP gene, and thus amplification does not take place.
Primers complementary to sequences within the ATIP gene of VV-WR (1) and CPV-BR (15) were originally described by Meyer et al. (27). The sizes of the amplicon were expected to be 564 for VV-WR and 566 bp for CPV-BR. ATIP-PCRs were performed with the same apparatus and with the same volume and ingredients in the premix as for the TK-PCR, except that the ATIP primers were used at final concentrations of 0.2 µM (each). CPV-BR DNA served as a positive control. Running conditions were 40 cycles of denaturation at 94°C for 30 s, annealing at 58°C for 30 s, and extension at 72°C for 30 s. After the last cycle, 72°C was held for 10 min more. All samples were kept at 4°C before analysis. The further processing of the samples was done under conditions identical to those for the TK-PCR samples, except that the probe was made by labeling 45 ng of a 165-bp internal BglII (New England Biolabs, Inc.) fragment of the CPV-BR ATIP-PCR amplicon.| |
RESULTS |
|---|
|
|
|---|
Specificity and sensitivity of the PCR method. According to computer-based sequence analysis, the TK primers could promote the amplification of DNA from all orthopoxvirus species that have been demonstrated in Europe. A 100% identity in a 20-bp overlap was found for both primers when the GCG database TK sequences for vaccinia virus, monkeypox virus, and variola virus were aligned. For camelpox virus, there was one mismatch at the 3' end of the ortho-TK-2 primer. The TK-PCR amplicons from VV-WR, CPV-BR, and ectromelia virus DNA appeared as a single DNA band with a size close to that of the 344-bp band of the 1-kb ladder.
The identities of the PCR amplicons as orthopoxvirus TK gene products were verified by two procedures. The PCR amplicons from the orthopoxvirus reference strains were (i) digested with the EcoRI (Promega) and BspDI (New England Biolabs, Inc.) endonucleases and shown to yield the expected fragment patterns (Fig. 2) and (ii) hybridized with a [
-32P]dCTP-labeled probe representing
226 bp of the vaccinia virus TK gene (Fig.
3). No hybridization could be detected
for fowlpox virus DNA (ATCC, VR-229).
|
|
10 µg given by Holowczak (16), 1 pg of
DNA corresponds to approximately 4,000 viral genomes. When PCR was
combined with blotting or hybridization, the detection level increased
100-fold (i.e., 10 fg of vaccinia virus DNA corresponding to 40 viral
particles could be detected [data not shown]).
The combination of PCR with blotting or hybridization revealed a higher
number of positive results than with PCR alone (Fig. 4). Of a total number of 1,388 samples,
only 14 samples turned out positive by PCR alone, whereas after
blotting and hybridization, the number of positive samples increased to
59 (i.e., the PCR alone could detect only 24% of the true-positive
samples). DNA samples from the 59 PCR- or hybridization-positive organs
were analyzed a second time in the same assay.
|
Occurrence and distribution of orthopoxviruses in Norway. A total number of 1,388 organs representing 347 animals were examined for the presence of orthopoxvirus TK gene sequences. The number and origin of animals collected are shown in Table 1. Orthopoxvirus-specific DNA was detected in five of nine different animal species from five of eight locations (Fig. 5, locations 1, 4, 5, 6, and 8) and in 59 organs from 52 individual animals (Table 2). Virus DNA could be detected in wood mice (Apodemus sylvaticus), bank voles (Clethrionomys glareolus), northern red-backed voles (Clethrionomys rutilus), gray-sided voles (Clethrionomys rufocanus), and common shrews. No statistically significant correlation was found between prevalence and species. Thus, no specific species could be pointed out as a one-reservoir host. Concerning different tissues, 13.5% of the lung samples were positive, compared to 0.8, 1.4, and 2.0% of the liver, kidney, and spleen samples, respectively.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
There are at least three good reasons to investigate the occurrence, distribution, and characteristics of zoonotic orthopoxviruses. First, one viral species, cowpox virus, is a proven pathogen for humans and some domestic animals (5, 29). Second, the potential of such viruses to evoke disease in wildlife species is unknown, although it is well documented that they are highly pathogenic for several zoo-kept animals (4, 23, 34, 44). Third, the use of vaccinia virus and other orthopoxviruses as live vaccine vectors (33) makes the prospect of recombinant progeny between naturally circulating and released or escaped genetically modified orthopoxviruses an urgent matter.
The geographical distribution of the various small rodent species had a major impact on the selection of trapping locations. In general, field voles, Norway lemmings, and common shrews are found all over the country. The bank vole is present in most parts of Norway, except the northernmost part, where the northern red-backed vole lives. Gray-sided voles are found all over the country, except along the coast in the southernmost part. The wood mouse lives along the coast in the southern part of Norway. The root vole is present in mountain areas in the south and cold areas in the north. In order to cover such a spectrum of ecosystems, both inland and coastal ecosystems representative of the country were selected. We included new trapping locations in 1995, taking into consideration the two clinical cases of cowpox virus infection that appeared the previous year (Fig. 5, locations 4 and 5).
Information about the distribution of orthopoxviruses within the bodies of small mammalian species that are present in Norway was lacking. We chose target tissues for DNA extraction and TK-PCR analysis based on information about ectromelia virus tissue tropism in laboratory mice (9) and successful attempts at isolation of cowpox virus from rodents (25), although these involved rodent species not present in Norway.
In the present study, we used a primer set complementary to the highly conserved orthopoxvirus TK gene to be able to detect several members of the orthopoxvirus genus (8). Of a total of 1,388 organs, 59 organ samples contained orthopoxvirus DNA (Table 2). The ATIP-PCR detected 69% of the TK-PCR-positive samples. The dropping out of 31% of the samples is probably due to an ATIP-PCR with a lower sensitivity than the TK-PCR. Comparison of the two PCR assays for animals that were TK positive for two or more organs indicates that this is correct.
Several of the known orthopoxvirus species have been isolated from rodents (10, 24, 35), and ectromelia virus, formerly believed to infect laboratory mice only (14), has recently been isolated from fur-bearing foxes and minks in the Czech Republic (22). Since the ATIP-PCR used in this study is unable to detect DNA from ectromelia virus but revealed positive samples among the mammals investigated, we conclude that the origin of the orthopoxvirus DNA is not ectromelia virus. Furthermore, we think that it is unlikely that vaccinia virus is endemic in the small mammals examined here. It is more reasonable to believe that some cowpox virus or viruses are involved. Final conclusions concerning the identity of Norwegian orthopoxviruses circulating in small mammal populations can only be done by isolation and characterization.
Common shrews represent 45% of our total animal collection and were trapped at all locations, except Søgne and Hardangervidda. TK-PCR-positive common shrews were only found at Austrheim and Kalandsvatn (Fig. 5, locations 4 and 5). The fact that rodent species but no common shrews were TK-PCR positive at other locations may reflect qualitative differences in the distribution of virus in small mammal colonies at different sites. On the other hand, the explanation may be that none of the species included in these investigations are real reservoir animals, but are running through infections newly received from some as-yet-unidentified reservoir species. This would again imply that the amount of contact between these unknown natural reservoirs and common shrews differs among our trapping locations.
We still do not know whether any of the orthopoxvirus-infected species are natural reservoirs for such viruses, but the body weight and the time of collection for some virus-infected individuals provide leads for further work. For instance, six virus-infected gray-sided voles and northern red-backed voles collected in June 1993 in Masi (Fig. 5, location 1) had body weights ranging from 29 to 50 g. These animals must have overwintered, and if they have been persistently infected from the preceding year, these vole species should be considered a natural orthopoxvirus reservoir. Another situation is illustrated by the bank vole collection from Kongsvinger in August 1993 (Fig. 5, location 8). The animals with body weights ranging from 13.5 to 18 g have most certainly been born that summer season, and one may therefore assume that orthopoxvirus activity and transmission have occurred that season.
Previous serological surveys of British wildlife have detected orthopoxvirus-specific antibodies in several rodent species, including bank voles and wood mice (12, 19), but unfortunately, no final conclusions concerning the species of orthopoxvirus eliciting these antibodies could be drawn. The same investigations also demonstrated extreme variations in prevalence between different geographical locations, similar to those recorded in the serological studies in Norway as well as in the present study. Serological assays are unable to detect acute infections in which seroconversion has not occurred. Antibody prevalence may give an estimate of the total infection rate, but does not reveal the frequency of virus carriers at any given time. PCR gives the prevalence of virus-infected individuals within a population at the moment of sampling and important information about the organs involved in an infection. However, by using PCR as a screening method for infections with an unknown pathogenesis, there is a risk of missing organs involved in infection.
Lung samples are heavily overrepresented among the positive samples. This may indicate that the respiratory organs are ports of entry into the organism, but may also be a phenomenon secondary to systemic spread of virus. Orthopoxvirus was, to a lesser extent, detected in spleens, livers, and kidneys, allowing the conclusion that orthopoxvirus or viruses may cause systemic infections in small wild mammals. It is, however, still unknown whether disease is ever evoked. In Turkmenia, cowpox viruses were isolated from big gerbils and yellow susliks that were apparently healthy (25), and we have not observed any clinical symptoms among the animals collected so far.
| |
ACKNOWLEDGMENTS |
|---|
We thank Bjarne Johansen, Ole Morten Seternes, and Soma Vignarjan, Department of Virology, Institute of Medical Biology, University of Tromsø, Norway, for assistance in the laboratory.
These studies were supported by grants from the Norwegian Research Council program "Environmental effects of biotechnology."
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Virology, Institute of Medical Biology, University of Tromsø, N-9037 Tromsø, Norway. Phone: (47) 77644621. Fax: (47) 77645350. E-mail: terjet{at}fagmed.uit.no.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Amegadzie, B. Y., J. R. Sisler, and B. Moss. 1991. Frame-shift mutations within the vaccinia virus A-type inclusion protein gene. Virology 186:777-782. |
| 2. | Baxby, D. 1977. Is cowpox misnamed? Br. Med. J. 1:1379-1381. |
| 3. | Baxby, D. 1977. Poxvirus hosts and reservoirs. Arch. Virol. 55:169-179[Medline]. |
| 4. | Baxby, D., D. G. Ashton, D. M. Jones, and L. R. Thomsett. 1982. An outbreak of cowpox in captive cheetahs: virological and epidemiological studies. J. Hyg. 89:365-372. |
| 5. | Baxby, D., and M. Bennett. 1994. Cowpox virus, p. 261-267. In R. G. Webster, and A. Granoff (ed.), Encyclopedia of virology. Academic Press, London, United Kingdom. |
| 6. | Baxby, D., M. Bennett, and B. Getty. 1994. Human cowpox 1969-93: a review based on 54 cases. Br. J. Dermatol. 131:598-607[Medline]. |
| 7. | Bennett, M., C. J. Gaskell, D. Baxby, R. M. Gaskell, D. F. Kelly, and J. Naidoo. 1990. Feline cowpox virus infection. J. Small Anim. Pract. 31:167-173. |
| 8. | Binns, M., J. Mumford, and U. Wernery. 1992. Analysis of the camelpox virus thymidine kinase gene. Br. Vet. J. 148:541-546[Medline]. |
| 9. |
Buller, R. M. L., and G. J. Palumbo.
1991.
Poxvirus pathogenesis.
Microbiol. Rev.
55:80-122 |
| 10. | Causey, O. R., and G. E. Kemp. 1968. Surveillance and study of viral infections of vertebrates in Nigeria. Nigerian J. Sci. 2:131-135. |
| 11. |
Church, G. M., and W. Gilbert.
1984.
Genomic sequencing.
Proc. Natl. Acad. Sci. USA
81:1991-1995 |
| 12. | Crouch, A. C., D. Baxby, C. M. McCracken, R. M. Gaskell, and M. Bennett. 1995. Serological evidence for the reservoir hosts of cowpox virus in British wildlife. Epidemiol. Infect. 115:185-191[Medline]. |
| 13. | Esposito, J. J., and J. C. Knight. 1984. Nucleotide sequence of the thymidine kinase gene region of the monkeypox and variola viruses. Virology 135:561-567[Medline]. |
| 14. | Fenner, F., R. Wittek, and K. R. Dumbell. 1989. The orthopoxviruses. Academic Press, Inc., San Diego, Calif. |
| 15. |
Funahashi, S.,
T. Sato, and H. Shida.
1988.
Cloning and characterization of the gene encoding the major protein of the A-type inclusion body of cowpox virus.
J. Gen. Virol.
69:35-47 |
| 16. | Holowczak, J. H. 1982. Poxvirus DNA. Curr. Top. Microbiol. Immunol. 97:27-79[Medline]. |
| 17. |
Hruby, D. E.,
R. A. Maki,
D. B. Miller, and L. A. Ball.
1983.
Fine structure analysis and nucleotide sequence of the vaccinia virus thymidine kinase gene.
Proc. Natl. Acad. Sci. USA
80:3411-3415 |
| 18. | Innis, M. A., D. H. Gelfand, J. J. Sninsky, and T. J. White. 1990. PCR protocols: a guide to methods and applications. Academic Press, Inc., San Diego, Calif. |
| 19. | Kaplan, C., T. D. Healing, N. Evans, L. Healing, and A. Prior. 1980. Evidence of infection by viruses in small British field rodents. J. Hyg. Camb. 84:285-294. |
| 20. | Kwok, S., and R. Higuchi. 1989. Avoiding false positives with PCR. Nature (London) 339:237-238[Medline]. |
| 21. | Mahnel, H. 1991. Katzenpocken in Deutschland. Tieraerztl. Prax. 19:419-422. |
| 22. | Mahnel, H., J. Holejsovsky, P. Bartak, and C.-P. Czerny. 1993. Kongenitale "Ektromelie" bei Pelztieren durch Orthopoxvirus muris. Tieraerztl. Prax. 21:469-472. |
| 23. | Marennikova, S. S., N. N. Maltseva, V. L. Korneeva, and N. M. Garanina. 1977. Outbreak of pox disease among Carnivora (Felidae) and Edentata. J. Infect. Dis. 135:358-366[Medline]. |
| 24. | Marennikova, S. S., I. D. Ladnyi, Z. I. Ogorodnikova, E. M. Shelukhina, and N. N. Maltseva. 1978. Identification and study of a poxvirus isolated from wild rodents in Turkmenia. Arch. Virol. 56:7-14[Medline]. |
| 25. | Marennikova, S. S. 1979. Field and experimental studies of poxvirus infections in rodents. Bull. W. H. O. 57:461-464[Medline]. |
| 26. | Marennikova, S. S., E. M. Shelukhina, and E. V. Efremova. 1984. New outlook on the biology of cowpox virus. Acta Virol. 28:437-444[Medline]. |
| 27. |
Meyer, H.,
M. Pfeffer, and H.-J. Rziha.
1994.
Sequence alterations within and downstream of the A-type inclusion protein genes allow differentiation of Orthopoxvirus species by polymerase chain reaction.
J. Gen. Virol.
75:1975-1981 |
| 28. | Moss, B. 1996. Poxviridae: the viruses and their replication, p. 2637-2671. In B. N. Fields, D. M. Knipe, P. M. Howley, et al. (ed.), Fields' virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa. |
| 29. | Munz, E., S. Linckh, and I. C. E. Renner-Müller. 1992. Infektionen mit originärem Kuhpockenvirus und kuhpockenähnlichen Erregern bei Mensch und Tier: eine Literaturübersicht. J. Vet. Med. 39:209-225. |
| 30. | Myrmel, H., G. Haukenes, L. Rustad, L. Holtet, and J. Gallefoss. 1997. Et tilfelle av kukopper. Tidsskr. Nor. Laegeforen. 24:3504-3505. |
| 31. | Nowotny, N. 1994. The domestic cat: a possible transmitter of viruses from rodents to man. Lancet 343:921[Medline]. |
| 32. | Osterrieder, N., H. Meyer, and M. Pfeffer. 1994. Characterization of the gene encoding the A-type inclusion body protein of mousepox virus. Virus Genes 8:125-135[Medline]. |
| 33. | Perkus, M. E., J. Tartaglia, and E. Paoletti. 1995. Poxvirus-based vaccine candidates for cancer, AIDS, and other infectious diseases. J. Leukocyte Biol. 58:1-13[Abstract]. |
| 34. | Pilaski, J., and F. Jacoby. 1993. Die Kuhpocken-Erkrankungen der Zootiere. Verh. Erkrg. Zootiere. 35:39-50. |
| 35. | Regnery, D. C. 1987. Isolation and partial characterization of an orthopoxvirus from a California vole (Microtus californicus). Arch. Virol. 94:159-162[Medline]. |
| 36. | Rolfs, A., I. Schuller, U. Finckh, and I. Weber-Rolfs. 1992. PCR: clinical diagnostics and research. Springer-Verlag, Berlin, Germany. |
| 37. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 38. | Schönbauer, M., A. Schönbauer-Langle, and S. Kölbl. 1982. Pockeninfektion bei einer Hauskatze. Zentbl. Vetmed. 29:434-440. |
| 39. | Tryland, M., T. Sandvik, R. Mehl, M. Bennett, T. Traavik, and Ø. Olsvik. 1998. Serological evidence for orthopoxvirus infection in Norwegian rodents and shrews. J. Wildl. Dis. 34:240-250[Abstract]. |
| 40. | Tryland, M., T. Sandvik, J. M. Arnemo, G. Stuve, Ø. Olsvik, and T. Traavik. 1998. Fennoscandian wild carnivores have antibodies against orthopoxviruses. J. Wildl. Dis. 34:443-450[Abstract]. |
| 41. | Tryland, M., T. Sandvik, L. Holtet, G. Haukenes, Ø. Olsvik, and T. Traavik. 1996. Cowpoxvirus-infeksjon påvist hos katt i Norge. Nor. Veterinaertidsskr. 108:13-18. |
| 42. | Tryland, M., T. Sandvik, H. Hansen, G. Haukenes, L. Holtet, R. Mehl, U. Moens, Ø. Olsvik, and T. Traavik. Characterization and comparative studies of Scandinavian cowpox virus isolates. APMIS, in press. |
| 43. | Willemse, A., and H. F. Egberink. 1985. Transmission of cowpox virus infection from domestic cat to man. Lancet i:1515. |
| 44. | Zwart, P., R. Gispen, and J. C. Peters. 1971. Cowpox in okapis Okapia Johnstoni at Rotterdam Zoo. Br. Vet. J. 127:20-24[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»